Related Experiment Video
Updated: Aug 9, 2026
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
Lymphatic mapping and sentinel node biopsy for melanoma
1Sydney Melanoma Unit, Royal Prince Alfred Hospital, Department of Surgery, University of Sydney, Sydney, New South Wales, Australia.john@mel.rpa.cs.nsw.gov.au
Expert Review of Anticancer Therapy
|July 13, 2002
Summary
Sentinel node biopsy accurately stages melanoma by reflecting regional lymph node status. This technique is crucial for accurate melanoma staging and guiding adjuvant therapy trials.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Sentinel nodes (SNs) are the first regional lymph nodes to receive lymphatic drainage from a tumor.
- Accurate assessment of SN status is critical for melanoma staging and treatment decisions.
Purpose of the Study:
- To confirm the reliability of sentinel node biopsy for melanoma staging.
- To highlight the importance of preoperative lymphoscintigraphy and intraoperative techniques for SN identification.
Main Methods:
- Preoperative lymphoscintigraphy to identify SNs and map lymphatic pathways.
- Intraoperative SN identification using blue dye injection and a gamma-probe.
- Histological examination of SNs to determine metastatic status.
Main Results:
- Histological status of SNs accurately reflects the status of regional lymph nodes in melanoma patients.
- Lymphoscintigraphy effectively identifies SNs and unusual lymphatic drainage.
- Combined techniques (blue dye and gamma-probe) maximize surgical accuracy.
Conclusions:
- Sentinel node biopsy provides highly accurate staging for melanoma patients.
- Close multidisciplinary collaboration is essential for reliable SN biopsy.
- SN biopsy is indispensable for melanoma patients in adjuvant therapy trials.
